Author(s):
Mayuri B. Patil, Priyanka M. Salve, Shital V. Sonawane, Avish D. Maru, Jayshree S. Bhadane, Rajendra K. Surawase
Email(s):
mayuripatil252627@gmail.com
DOI:
10.52711/0975-4377.2021.00042 
Address:
Mayuri B. Patil*, Priyanka M. Salve, Shital V. Sonawane, Avish D. Maru, Jayshree S. Bhadane, Rajendra K. Surawase
Loknete Dr. J. D. Pawar College of Pharmacy, Manur, Tal - Kalwan, Dist – Nashik - 423501.
*Corresponding Author
Published In:
Volume - 13,
Issue - 3,
Year - 2021
ABSTRACT:
Bilayer tablet is a recent time for the successful development of controlled release formulation along with various quality to provide a way of the successful drug delivery system. Over the past 30 years stated that the cost and complications involved in marketing new drug entities have increased, with consequent recognition of therapeutic advantages of controlled drug delivery, greater attention has been concentration on development of sustained or controlled release drug delivery systems. Bilayer tablet it is used in the different aspect for anti-inflammatory and analgesic. Bilayer tablet incidental release of two drugs in combination, separate two incompatible substance and also for sustained release tablet in which one layer is immediate release as initial dose and second layer is maintenance dose. Bilayer tablet is enhancing beneficial technology to control the shortcoming of the single layered tablet. There is various application used in the bilayer tablets.
Cite this article:
Mayuri B. Patil, Priyanka M. Salve, Shital V. Sonawane, Avish D. Maru, Jayshree S. Bhadane, Rajendra K. Surawase. Technologies in Bilayer Tablet Manufacturing: A Review. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):253-258. doi: 10.52711/0975-4377.2021.00042
Cite(Electronic):
Mayuri B. Patil, Priyanka M. Salve, Shital V. Sonawane, Avish D. Maru, Jayshree S. Bhadane, Rajendra K. Surawase. Technologies in Bilayer Tablet Manufacturing: A Review. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):253-258. doi: 10.52711/0975-4377.2021.00042 Available on: https://rjpdft.com/AbstractView.aspx?PID=2021-13-3-13
REFERENCES:
1. Micheal, A.E. Modified release per oral dosage forms, Pharmaceutics- The Science of Dosage form design, Churchill Livingstone New York, (2002), pp. 575.
2. Mohideen S and Satyanarayana T. Development and evaluation of two layered tablet of glimepiride and metformin hydrochloride for the treatment of hyperglycemia. Inter J Bio Pharam.2011; 2(1): pp. 31-35.
3. Swarbrick J. Chien Y W. Fundamentals of controlled-release of drug administration in Novel Drug Delivery System, Marcel Dekker, New York, 2nd edition, (1982), pp.465-574.
4. Chun YW, JW, Jonathan PK, A Comparative Study of Compaction of Binary and Bilayer Tablets, Powder Technology, Science Direct, 189, (2009), pp. 285-294.
5. Hoffman A and Stepensky, Pharmacodynamics Aspects of modes of Drug Administration for Optimization of Drug Therapy. Crit.Rev. Their. Drug. Carrier. Sys. (1999).16, pp. 571-639.
6. Rang HP, Dale MM, Ritter JM, Moore PK, Rang and Dale’s pharmacology. 6th Edn, Elsevier. (2007).
7. Banker, S., Gilbert, J., Rhodes, T. Christopher, Modern Pharmaceutics, Marcel Dekker, Inc., New York, pp. 575.
8. Yadav a and Jain DK. Formulation development and in vitro characterization of player and floating bio adhesive tablets of propranolol hydrochloride, Asia J Phar Life Scie. (2011); 1(1): 2.
9. Buri P, Puisicux F, Doelker E, Benoit J P. Formes Pharma centiques nouvelles, Ed. Technique et Documentation, Lavoisier, Paris, (1985).
10. Aggarwal swati, Syan N, Mathur P, Bilayer Tablet Technology-Opening New Ways in Drug Delivery System: An Overview, International Journal of research In Pharamaceutical and Biomedical Sciences, (2013)4(1),), pp. 8-16.
11. Li, S. P. Evaluation of Bilayer tablet machines. A Case study. Drug Development and Industrial Pharmacy, (1995).21(15), pp. 571-590.
12. Dey S and Chatto PS. Formulation and evaluation of fixed dose combination of bilayer gastro retentive matrix tablet containing atorvastatin as fast release and atenolol as sustained release. Biomed Res Inter.2014; 10(1155): 396106.
13. Wilding I R, Coupe A J, Davis S S. The role of gamma scintigraphy in oral drug delivery, Adv. Drug Deliv. Rev, 7, (1991), pp. 87-117.
14. Malathi Parnapalli, Arshad BK, Recent Approaches in Bilayered Technology: Review, International Journal of Pharmaceutical Science and Research, 3(12), (2012), pp. 4681-4688.
15. Lee L. Diffusion-controlled matrix systems, in: A Kydonieus (Ed.), Treatise on Controlled Drug Delivery, Marcel Dekker, New York, (1992), pp. 155-198.
16. Nilawar M P S. An Emerging Trend on Bilayer Tablets, International Journal of Pharmacy and Pharmaceutical Science Research, (2013) 3(1), pp. 15-21.
17. Banu H and Sahariar MR. Formulation development of bi-layer acetaminophen tablets for extended drug release. J Chem Pharma Res. (2011); 3(6): pp. 348-360.
18. Sandeep N and GuptaMM. Immediate drug release dosage forms a review. JDDT. (2013); 3(2): pp.155-161.
19. Ali SH and Reddy BR. Formulation and evaluation of bilayer tablet of atorvastatin and pioglitazone for metabolic disorder. IAJPS. (2014) ;(6): pp.448-455.
20. Lachman L, Liberman H and Kanig J. The theory and practice of industrial pharmacy. Varghese Publishing House, Mumbai. (1987); Edn: 297.
21. Solanki PD. Formulation evaluation and optimization of bilayer floating tablet of repaglinide and glipizide. Inter J Pharm Rese Schoc. (2012); 1(3): pp.123-134.
22. Indian Pharmacopoeia. The Controller of Publication, Delhi. (1996); 2:735.
23. Peppas N A, Boca Raton F L. Hydrogel in Medicine and Pharmacy, CRC Press, 1(2 and 3), (1998), pp. 65.
24. Kulkarni, S. Novel decongestant bilayer tablets in modified release dosage form using HPMC. Indian Journal of Pharmaceutical Sciences. (2000).5, pp. 508-509.
25. Debnath, M. Bilayer Tableting Technology: An Overview. Journal of Pharmacy Research, (2012).; 5(1), pp. 310-314.
26. Inman, S. J., Briscoe, B. J., Pitt, K. G., and Shin, C. The non-uniformity of microcrystalline cellulose bilayer tablets. Powder Technology, (2009).188(3), pp. 283-294.
27. A Tadavi, S., and Patel, M. R. Brief Overview on Compaction and Compression of Bilayer Technology. Journal of Pharmacy Research, (2011). 4(9), pp. 2987-2990.
28. Bhandari, a. Bilayer tablet oral solid drug delivery system and challenges in the formulation: a review, International Journal of Pharmaceutical research and Development, (2011)4(03), pp. 29-44.
29. Pujara, n. D., Gokani, R. K., and Paun, J. S. Bilayer tablet-an emerging trend. International Journal of Pharmaceutical Research and Development, (2012). 4(4), pp. 103-104.
30. WWW.durect.com
31. Singh, B. N., and Kim, K. H. Floating drug delivery system: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release, (2000). 63(3), pp. 235-259.
32. Sharma V, Nagpal M, Jain UK, Mangotia A and Kumar R. Antidiabetic drug and combination therapy. ARPB. (2013); 3(2): pp.389-394.
33. Kumar HA, Kavitha K, Kumar SA, Kumar RM and Singh JSD.Novel approach of bilayer tablet technology are view. IJPCBS. (2013); 3(3): pp.887-893.